| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 06/04/2009 | WO2009069727A1 Method for chemically modifying biopolymer or polypeptide |
| 06/04/2009 | WO2009069504A1 Protein adsorbent and method for producing the same |
| 06/04/2009 | WO2009069036A1 Selective enrichment of post-translationally modified proteins |
| 06/04/2009 | WO2009069035A1 Selective enrichment of post-translationally modified proteins and/or peptides from complex samples |
| 06/04/2009 | WO2009069033A1 Selective enrichment of post-translationally modified proteins and/or peptides |
| 06/04/2009 | WO2009050261A9 Preparation of samples for proteome analysis |
| 06/04/2009 | WO2008075966A3 Synthesis of a radiofluorinated peptide using photolabile protecting groups |
| 06/04/2009 | WO2007018585A3 Process for controlling protein to salt ratio in animal muscle protein composition and protein composition |
| 06/04/2009 | WO2007009065A3 Methods of treating autoimmune disease using humanized anti-cd16a antibodies |
| 06/04/2009 | WO2001055301A3 Nucleic acids, proteins, and antibodies |
| 06/04/2009 | US20090143570 Method for isolation of genomic dna, rna and proteins from a single sample |
| 06/04/2009 | US20090143529 Peptide purification by means of hard metal ion affinity chromatography |
| 06/04/2009 | US20090142851 Method for selectively recovering c-terminal peptide of protein and method for determining amino acid sequence of c-terminal peptide of protein using the same |
| 06/04/2009 | US20090142786 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/04/2009 | CA2706611A1 Protein-adsorbing material and method for producing the same |
| 06/04/2009 | CA2705267A1 Method for isolation of genomic dna, rna and proteins from a single sample |
| 06/03/2009 | EP2065468A1 Modifications of hiv env enhance immunogenicity for genetic immunization |
| 06/03/2009 | EP2064334A2 Aldehyde tags, uses thereof in site-specific protein modification |
| 06/03/2009 | EP2064290A2 Fluorogenic ph sensitive dyes and their method of use |
| 06/03/2009 | EP2064226A2 Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators |
| 06/03/2009 | EP1869465A4 Protein microarray system |
| 06/03/2009 | EP1749021B1 Method and kit for isolating phosphorylated peptides |
| 06/03/2009 | EP1240200B1 Separation of fibrinogen from plasma proteases |
| 06/03/2009 | CN201250194Y Device for recovering protein in potato starch production waste water with membrane method |
| 06/03/2009 | CN101445548A Method for extracting protein of traditional Chinese medicine fleece-flower root and application thereof |
| 06/03/2009 | CN101445547A Method for preparing fishskin collagen with high molecular weight in a thermal-dissolving way at low temperature |
| 06/03/2009 | CN101445546A Preparation for tussore silk fibroin solution and concentration method thereof |
| 06/02/2009 | US7541328 Coupling proteins to a modified polysaccharide |
| 06/02/2009 | US7541170 Binding; amplification of nucleotide sequences; fusion proteins |
| 06/02/2009 | US7541139 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins |
| 06/02/2009 | CA2178208C Purification of vitamin-k dependent proteins by membrane chromatography |
| 05/28/2009 | WO2009067642A2 Removing polypeptides from stool |
| 05/28/2009 | WO2009067242A2 Co-crystal of antibody 11f8 fab fragment and egfr extracellular domain and uses thereof |
| 05/28/2009 | WO2009067068A1 Method for production and purification of macromolecular complexes |
| 05/28/2009 | WO2009066806A1 Purification method of human erythropoietin |
| 05/28/2009 | WO2009066454A1 Abnormal prion protein binder, and method for detection of abnormal prion protein |
| 05/28/2009 | WO2009065949A2 Peptide production and purification process |
| 05/28/2009 | WO2009065836A1 Process for the manufacture of persilylated peptides |
| 05/28/2009 | WO2009023047A3 Methods for the directed expansion of epitopes for use as antibody ligands |
| 05/28/2009 | WO2008073620A3 Manufacturing process for the production of polypeptides expressed in insect cell-lines |
| 05/28/2009 | US20090137786 Method for producing reduced keratin, reduced cuticle protein and mixture thereof |
| 05/28/2009 | US20090137780 Method for production of peptide thioester compound |
| 05/28/2009 | US20090137763 Glucosamine nucleotide sugars |
| 05/28/2009 | US20090137736 Accelerants for the Modification of Non-Natural Amino Acids and Non-Natural Amino Acid Polypeptides |
| 05/28/2009 | US20090137631 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression |
| 05/28/2009 | US20090137419 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/28/2009 | US20090137064 Ligand molecule-immobilized polymer, ligand molecule-immobilized particle, method of detecting target substance, and method of separating target substance |
| 05/28/2009 | US20090136983 Target sequences for synthetic molecules |
| 05/28/2009 | US20090136960 Methods and compositions for the identification of cancer markers |
| 05/28/2009 | US20090136959 Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other uses |
| 05/28/2009 | US20090136934 Targeting and tracing of antigens in living cells |
| 05/28/2009 | US20090136932 Fibers with isolated biomolecules and uses thereof |
| 05/28/2009 | US20090136649 Protein having ice nucleation activity |
| 05/28/2009 | US20090136538 Stable vaccine formulation |
| 05/28/2009 | US20090136420 Neoplasm-specific polypeptides and their uses |
| 05/28/2009 | CA2707007A1 Peptide production and purification process |
| 05/28/2009 | CA2705871A1 Abnormal prion protein binder, and method for detection of abnormal prion protein |
| 05/28/2009 | CA2705693A1 Process for the manufacture of persilylated peptides |
| 05/27/2009 | EP2062912A1 Selective enrichment of post-translationally modified proteins and/or peptides |
| 05/27/2009 | EP2062911A1 Selective enrichment of post-translationally modified proteins |
| 05/27/2009 | EP2062910A1 Selective enrichment of post-translationally modified proteins and/or peptides from complex samples |
| 05/27/2009 | EP2062909A1 Peptide production and purification process |
| 05/27/2009 | EP2061805A1 Recombinant hcv e2 glycoprotein |
| 05/27/2009 | EP2061803A1 Process for the purification of fc-containing proteins |
| 05/27/2009 | EP2061802A1 Process for the purification of fc-fusion proteins |
| 05/27/2009 | EP2061572A1 Controllable binding and dissociation of chemical entities and electrode devices therefore |
| 05/27/2009 | EP2061339A1 A method for preparing protein concentrate from rice bran |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP0832228B1 Modified hemoglobin-like compounds and methods of purifying same |
| 05/27/2009 | CN101443664A Mass tags for quantitative analyses |
| 05/27/2009 | CN101443347A Use of sphingosylphosphorylcholine antagonist for restoring the expression of antimicrobial peptides |
| 05/27/2009 | CN101443035A Vaccine for treatment or prophylaxis therapy of myasthenia gravis |
| 05/27/2009 | CN101440390A Method for preparing vegetable seed active peptide by mixed bacteria solid-state fermentation |
| 05/27/2009 | CN101440127A Preparation of high-purity vancomycin hydrochloride |
| 05/27/2009 | CN101440123A Novel process for synthesizing tetrapeptide (TFA-GLy-Pro-Thr-Ala-OH) |
| 05/27/2009 | CN101440122A Novel process for synthesizing dipeptide (TFA Thr-Ala-OH) |
| 05/27/2009 | CN101440121A System for separating protein polypeptide in blood serum and reagent kit thereof |
| 05/27/2009 | CN101440120A Preparation of microprotein |
| 05/27/2009 | CN100491395C Process for producing modified peptide |
| 05/27/2009 | CN100491394C Anti-angiogenic polypeptides |
| 05/27/2009 | CN100491390C Reversible packaged micro fluent chip for separating and purifying biological sample |
| 05/27/2009 | CN100491348C Thrombosis resisting preparation |
| 05/26/2009 | US7538198 Methods for protein refolding |
| 05/26/2009 | US7538190 cross metathesis; hydrogenation; stereoselective; synthesis of peptides with one or more intramolecular bridges |
| 05/26/2009 | US7538189 Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution |
| 05/26/2009 | US7538182 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 05/26/2009 | US7538091 D-retro-inverso amino acid sequence transporter peptide conjugated to nucleic acid biological effector; translocation across the membrane of pancreatic B-cells |
| 05/26/2009 | US7538084 Cyclosporins |
| 05/26/2009 | CA2295322C Methods and compositions for rapid purification of proteasomes and methods of use of components thereof |
| 05/26/2009 | CA2230492C Human growth hormone variants |
| 05/22/2009 | WO2009064637A1 Indole grafted solid support for fmoc-solid phase peptide synthesis |
| 05/22/2009 | WO2009063647A1 Antibody production method |
| 05/22/2009 | WO2009063069A2 Protein purification and endotoxin removal |
| 05/22/2009 | WO2009062942A2 Dual affinity polypeptides for purification |
| 05/22/2009 | WO2006127865A3 Bioresponsive hydrogels |
| 05/22/2009 | WO2006126188A3 Cxcr4 antagonists for wound healing and re-epithelialization |
| 05/22/2009 | CA2705765A1 Method of efficient extraction of protein from cells |
| 05/22/2009 | CA2705334A1 Dual affinity polypeptides for purification |
| 05/22/2009 | CA2702971A1 Antibody production elicited by a dna vaccine delivered by electroporation |
| 05/21/2009 | US20090133134 Method and composition for genetically modifying non-human cells and animals |